RegeneRx extends expiration dates of warrants sold in 2005

By Devika Patel

Knoxville, Tenn., Jan. 7 - RegeneRx Biopharmaceuticals, Inc. amended the terms of warrants sold in a $4.61 million private placement that settled in January 2005, according to an 8-K filed Monday with the Securities and Exchange Commission.

As previously reported, RegeneRx sold shares and warrants exercisable at $4.06 each for three years. The warrants were set to expire between Dec. 31, 2007 and Jan. 7, 2008.

ThinkEquity Partners LLC was the placement agent in the deal and also received a three-year warrant to buy 11,539 common shares.

Effective Dec. 31, RegeneRx extended the expiration dates of each warrant to March 31 and eliminated the cashless exercise provisions of the warrants. It may extend the expiration further.

Based in Bethesda, Md., RegeneRx is a biopharmaceutical company focused on the treatment of acute and chronic wounds.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.